Santen Pharmaceutical Co., Ltd. Announces Year End Dividend for the Year Ended March 31, 2024, Payable on June 26, 2024; Provides Dividend Guidance for the End of Second Quarter of 2025
May 09, 2024 at 02:00 am EDT
Share
Santen Pharmaceutical Co., Ltd. announced year end dividend for the year ended March 31, 2024 of JPY 17.00 per share compared to JPY 16.00 per share a year ago. Start of Distribution of Dividends (Scheduled): June 26, 2024.
The company provided dividend guidance for the end of second quarter of 2025. For the end of second quarter, the company expects to pay dividend of JPY 17.00 per share compared to JPY 16.00 per share a year ago.
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.
Santen Pharmaceutical Co., Ltd. Announces Year End Dividend for the Year Ended March 31, 2024, Payable on June 26, 2024; Provides Dividend Guidance for the End of Second Quarter of 2025
SANTEN PHARMACEUTICAL CO., LTD. 
